Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.74 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.66 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29421079 | 1.00 | MEN1 (0.74) | MEN1KMT2AADORA3ADORA1 | |
| SCHEMBL18503544 | 1.00 | MEN1 (0.74) | MEN1KMT2AADORA3ADORA1 | |
| SCHEMBL20449961 | 1.00 | MEN1 (0.74) | MEN1KMT2AADORA3ADORA1 | |
| SCHEMBL25098313 | 1.00 | MEN1 (0.74) | MEN1KMT2AADORA3ADORA1 | |
| SCHEMBL7197194 | 1.00 | MEN1 (0.74) | MEN1KMT2AADORA3ADORA1 | |
| SCHEMBL25097801 | 1.00 | MEN1 (0.74) | MEN1KMT2AADORA3ADORA1 | |
| SCHEMBL26501998 | 0.92 | MEN1 (0.63) | MEN1KMT2AADORA3ADORA1 | |
| SCHEMBL9413275 | 0.91 | MEN1 (0.62) | MEN1KMT2AADORA3ADORA1 | |
| SCHEMBL7922093 | 0.91 | MEN1 (0.73) | MEN1KMT2AADORA3ADORA1 | |
| SCHEMBL9413276 | 0.90 | MEN1 (0.72) | MEN1KMT2AADORA3ADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1593 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260034204-A1 | RNA ENCODING VIRUS-LIKE PARTICLES AND USES THEREOF | SEQIRUS INC (US) | 2026-02-05 | — | — | US | claimed |
| EP-4634380-A1 | INTERNAL RIBOSOME ENTRY SITES FOR IMPROVED POLYNUCLEOTIDE TRANSLATION | ModernaTX, Inc. (US) | 2025-10-22 | — | — | EP | claimed |
| WO-2025137275-A1 | NOVEL CAS NUCLEASES AND POLYNUCLEOTIDES ENCODING THE SAME | MODERNATX, INC. (US) | 2025-06-26 | — | — | WO | claimed |
| WO-2025124917-A1 | SMALL NON-CODING RNA NANOPORE SEQUENCING | HUMMINGBIRD DIAGNOSTICS GMBH (DE) | 2025-06-19 | — | — | WO | claimed |
| EP-4568697-A1 | RNA ENCODING VIRUS-LIKE PARTICLES AND USES THEREOF | Seqirus Inc. (US) | 2025-06-18 | — | — | EP | claimed |
| EP-4565692-A2 | INTERNAL RIBOSOME ENTRY SITES FOR IMPROVED POLYNUCLEOTIDE TRANSLATION | ModernaTX, Inc. (US) | 2025-06-11 | — | — | EP | claimed |
| EP-4561537-A2 | LIPID NANOPARTICLES FOR IMMUNOTHERAPY | TRUSTEES OF TUFTS COLLEGE (US) | 2025-06-04 | — | — | EP | claimed |
| WO-2025111430-A1 | CHEMICAL MODIFICATIONS IN mRNA POLY(A) TAIL | PRIME MEDICINE, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| US-20250101507-A1 | Methods of Analyzing Capped Ribonucleic Acids | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2025-03-27 | — | — | US | claimed |
| WO-2025034727-A1 | TRANSLATIONAL MODULATING ELEMENTS FOR MRNA MOLECULES CAPPED WITH 5'-CAP ANALOGS, MRNA MOLECULES INCLUDING THE SAME, AND METHODS USING THE SAME | YALE UNIVERSITY (US) | 2025-02-13 | — | — | WO | claimed |
| US-20210348224-A1 | Methods of Analyzing Capped Ribonucleic Acids | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2021-11-11 | — | — | US | claimed |
| US-20190175690-A1 | COMPOSITIONS AND METHODS FOR CARDIAC REPAIR | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2019-06-13 | — | — | US | claimed |
| EP-3460064-A1 | EFFICIENT PROTEIN EXPRESSION IN VIVO USING MODIFIED RNA (MOD-RNA) | The General Hospital Corporation d/b/a Massachusetts General Hospital (US) | 2019-03-27 | — | — | EP | claimed |
| US-10086043-B2 | Efficient protein expression in vivo using modified RNA (MOD-RNA) | THE GENERAL HOSPITAL CORPORATION (US) | 2018-10-02 | — | — | US | claimed |
| EP-2694660-B1 | EFFICIENT PROTEIN EXPRESSION IN VIVO USING MODIFIED RNA (MOD-RNA) | MASSACHUSETTS GEN HOSPITAL (US) | 2018-08-08 | — | — | EP | claimed |
| US-9719084-B2 | Co-transcriptional assembly of modified RNA nanoparticles | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES (US) | 2017-08-01 | — | — | US | claimed |
| US-20150203842-A1 | CO-TRANSCRIPTIONAL ASSEMBLY OF MODIFIED RNA NANOPARTICLES | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES | 2015-07-23 | — | — | US | claimed |
| US-20140073687-A1 | EFFICIENT PROTEIN EXPRESSION IN VIVO USING MODIFIED RNA (MOD-RNA) | IMMUNE DISEASE INSTITUTE, INC. (US) | 2014-03-13 | — | — | US | claimed |
| WO-2014039809-A2 | CO-TRANSCRIPTIONAL ASSEMBLY OF MODIFIED RNA NANOPARTICLES | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES (US) | 2014-03-13 | — | — | WO | claimed |
| US-20030007961-A1 | Orthomolecular vitamin E derivatives | WILBURN MICHAEL D (US) | 2003-01-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190175690-A1 | COMPOSITIONS AND METHODS FOR CARDIAC REPAIR | YAP1, TNNI3, FABP3 | MEN1 4403/4885KMT2A 1996/4885ADORA3 4202/4885 |
| US-20030007961-A1 | Orthomolecular vitamin E derivatives | RBP4, RBP1, VDR | MEN1 3493/4885KMT2A 4864/4885ADORA3 1274/4885 |
| US-20260034204-A1 | RNA ENCODING VIRUS-LIKE PARTICLES AND USES THEREOF | HNRNPA1, UPF1, PRNP | MEN1 2764/4885KMT2A 1929/4885ADORA3 735/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.